Clinical Trials Browser

Phase 4 × osimertinib × Thoracic × Clear all

NCT05785208 2023-03-27

TEMPLE-2

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03853551 2021-06-03

Osimertinib Study in Indian Patients

Phase 4 Completed

60 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung